Drug Shortage Report for DIPENTUM
| Report ID | 188443 |
| Drug Identification Number | 02063808 |
| Brand name | DIPENTUM |
| Common or Proper name | Dipentum |
| Company Name | ATNAHS PHARMA UK LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | OLSALAZINE SODIUM |
| Strength(s) | 250MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A07EC |
| ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-07-05 |
| Actual start date | |
| Estimated end date | 2024-11-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-11-30 |
| Company comments | . |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | SOVEREIGN HOUSE, MILES GRAY ROAD BASILDON, ESSEX GREAT BRITAIN SS14 3FR |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-11-30 | French | Compare |
| v5 | 2023-11-30 | English | Compare |
| v4 | 2023-11-24 | French | Compare |
| v3 | 2023-11-24 | English | Compare |
| v2 | 2023-03-31 | French | Compare |
| v1 | 2023-03-31 | English | Compare |
Showing 1 to 6 of 6